Evon, Donna M.
Wahed, Abdus S.
Johnson, Geoffrey
Khalili, Mandana
Lisker-Melman, Mauricio
Fontana, Robert J.
Sarkar, Souvik
Reeve, Bryce B.
Hoofnagle, Jay H.
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (UO1-DK082867-01)
Article History
Received: 9 July 2015
Accepted: 14 December 2015
First Online: 30 January 2016
Compliance with ethical standards
:
: Mandana Khalili, Geoffrey Johnson, Wahed Abdus, Souvik Sarkar, and Jay Hoofnagle have no conflict of interests to disclose. Donna Evon has served as a consultant for Gilead. Robert Fontana has received research funding from BMS, Vertex, Gilead and Janssen, and has served as a consultant for GSK and Tibotec. Mauricio Lisker-Melman is on the Speaker’s Bureau for Gilead and Simply Speaking.